Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy (EBRT) had significantly reduced mortality rates....
Source: PhysOrg - Wednesday, 25 January
Related articles:
- Less than a day ago
- 1Vote! Fat removal reduces skin cancer in mice
Futurity.org - Yesterday
- 1Vote! With vitamin D, vaccine beats more cancer
- 1Vote! Folic Acid Food Fortification May Lower Risk of Rare Cancers
Yahoo Science News - Yesterday
- 1Vote! Sleep apnea associated with higher mortality from cancer
LabSpaces - Yesterday
- Less than a few days ago
- 6Vote! Non-Communicable Diseases Cause Most Deaths Worldwide -- Voice of America
Harvard World Health News - 4 days ago
- 5Vote! Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
- 5Vote! Genetic safety in numbers, platypus study finds
PhysOrg - 4 days ago
- Less than a week ago
- 4Vote! Coffee linked to lower risk of death
- 4Vote! Researchers find common antibiotic carries heart risk
- 5Vote! Predicting cancer relapse: Study finds high-throughput sequencing bests flow cytometry
- 5Vote! Images show risk of sudden heart failure
- 2Vote! Teens hit peak risk for painkillers at 16
- Older News
- 8Vote! A microRNA prognostic marker identified in acute leukemia
- 8Vote! Push to send patients home can backfire
- 8Vote! In wine country, trout struggle to survive
- 5Vote! Young Adults with Autism At Disadvantage After High School
- 3Vote! Test predicts prostate cancer relapse
- 3Vote! 'One in six cancers worldwide are caused by infection' -- BBC News
- 3Vote! Long-term use of osteoporosis medication may reduce bone fracture risk for some patients
- 5Vote! Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy
